Markofruct N
Markofruct N, licence 80095877: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Markofruct
- Licence holder
- Pascoe Canada
- NPN or DIN-HM
- 80095877
- Status
- Inactive licence
- Licence date
- 3 December 2019
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Inuline Source : Cichorium intybus - racine | 5.6 Grammes | Not calculated |
Non-medicinal ingredients
Maltodextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 1.0 packet | minimum: 1.0 Tous les jours ; maximum: 2.0 Tous les jours |
Uses authorised in Canada
Helps stimulate the growth of healthy bacteria (such as bifidobateria) in the intestine/gu. Prebiotic. Source of fiber for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you have diabetes, consult a health care practitioner prior to use. Consult a healthcare practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
- Effets indésirables connus
Please consult with your health care practitioner if you experience any side effects. Hypersensitivity has been known to occur. May cause mild gastro-intestinal discomfort (such as gas, bloating, cramps). Stop use if hypersensitivity/allergy occurs.
Source
Official Health Canada record, licence 80095877
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.